Insmed reports first quarter 2021 financial results and provides business update

Bridgewater, n.j., may 6, 2021 /prnewswire/ -- insmed incorporated (nasdaq:insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the first quarter ended march 31, 2021 and provided a business update.
INSM Ratings Summary
INSM Quant Ranking